Herein, we aimed to evaluate the association between serum NfL and S100B with the presence of neurological manifestations and functional prognosis in COVID-19 patients, while also considering comparison of biomarker levels with other clinical and laboratory variables. The gene discussed is S100B; the disease is COVID-19.